Predicting relapse after cessation of Lamivudine monotherapy for chronic hepatitis B virus infection.
Ito K, Tanaka Y, Orito E, Hirashima N, Ide T, Hino T, Kumashiro R, Kato A, Nukaya H, Sakakibara K, Mukaide M, Ito H, Sata M, Ueda R, Mizokami M.
Ito K, et al. Among authors: hirashima n.
Clin Infect Dis. 2004 Feb 15;38(4):490-5. doi: 10.1086/380965. Epub 2004 Jan 30.
Clin Infect Dis. 2004.
PMID: 14765340